About Vuja De Sciences
Vuja De Sciences is a company based in Hoboken (United States) founded in 2017.. Vuja De Sciences has raised $3.94 million across 10 funding rounds. Vuja De Sciences offers products and services including Discovery Platform. Vuja De Sciences operates in a competitive market with competitors including SpringWorks Therapeutics, QSAM Biosciences, ECM Therapeutics, Taithera and Atlanthera, among others.
- Headquarter Hoboken, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Vuja De Sciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.94 M (USD)
in 10 rounds
-
Latest Funding Round
$370 K (USD), Seed
Oct 04, 2024
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vuja De Sciences
Vuja De Sciences offers a comprehensive portfolio of products and services, including Discovery Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform identifies drugs targeting metastatic endurance in tumors.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Vuja De Sciences
Vuja De Sciences has successfully raised a total of $3.94M across 10 strategic funding rounds. The most recent funding activity was a Seed round of $370 thousand completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Seed — $370,000
-
First Round
First Round
(20 May 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Debt – Conventional - Vuja De Sciences | Valuation |
investors |
|
| Oct, 2024 | Amount | Seed - Vuja De Sciences | Valuation |
investors |
|
| Feb, 2024 | Amount | Seed - Vuja De Sciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Vuja De Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vuja De Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vuja De Sciences Comparisons
Competitors of Vuja De Sciences
Vuja De Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SpringWorks Therapeutics, QSAM Biosciences, ECM Therapeutics, Taithera and Atlanthera, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecule therapeutics are developed for cancer and rare diseases.
|
|
| domain | founded_year | HQ Location |
Developer of nuclear medicines for the treatment of bone cancer treatment & bone marrow ablation
|
|
| domain | founded_year | HQ Location |
Diagnostic and therapeutic products from extracellular matrix are developed.
|
|
| domain | founded_year | HQ Location |
Nanomedicine platform for targeted bone drug delivery is developed.
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for bone diseases and tumors are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vuja De Sciences
Frequently Asked Questions about Vuja De Sciences
When was Vuja De Sciences founded?
Vuja De Sciences was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is Vuja De Sciences located?
Vuja De Sciences is headquartered in Hoboken, United States. It is registered at Hoboken, New Jersey, United States.
Is Vuja De Sciences a funded company?
Vuja De Sciences is a funded company, having raised a total of $3.94M across 10 funding rounds to date. The company's 1st funding round was a Seed of $700K, raised on May 20, 2019.
What does Vuja De Sciences do?
Vuja De Sciences was founded in 2017 and is based in Hoboken, United States. Focus is placed on the biotechnology sector, specifically oncology, where therapies aimed at preventing cancer metastasis and recurrence are developed. A lead candidate, VUJ-100, is advanced using a proprietary platform that demonstrates anti-metastatic activity across models, including metastatic osteosarcoma and other cancers. Operations involve research and development for these therapeutic applications.
Who are the top competitors of Vuja De Sciences?
Vuja De Sciences's top competitors include SpringWorks Therapeutics, QSAM Biosciences and Taithera.
What products or services does Vuja De Sciences offer?
Vuja De Sciences offers Discovery Platform.